ALLOPURINOL KINETICS AND BIOAVAILABILITY - INTRAVENOUS, ORAL AND RECTAL ADMINISTRATION

被引：47

作者：

APPELBAUM, SJ

MAYERSOHN, M

DORR, RT

PERRIER, D

机构：

[1] UNIV ARIZONA, COLL PHARM, DEPT PHARM PRACTICE, TUCSON, AZ 85721 USA

[2] UNIV ARIZONA, COLL PHARM, DEPT PHARMACEUT SCI, TUCSON, AZ 85721 USA

[3] UNIV ARIZONA, COLL PHARM, RUTH E GOLDING CLIN PHARMACOKINET LAB, TUCSON, AZ 85721 USA

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1982年 / 8卷 / 01期

关键词：

D O I：

10.1007/BF00292878

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：93 / 98

页数：6

共 16 条

[1]

APPELBAUM SJ, 1980, DRUG INTEL CLIN PHAR, V14, P789

[2]

BENEZRA SA, 1978, ANAL PROFILES DRUG S, V7, P1

[3] STATISTICAL ESTIMATIONS IN PHARMACOKINETICS [J].

BOXENBAU.HG ;

RIEGELMA.S ;

ELASHOFF, RM .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02) :123-148

[4] BIOAVAILABILITY OF ALLOPURINOL ORAL AND RECTAL DOSAGE FORMS [J].

CHANG, SL ;

KRAMER, WG ;

FELDMAN, S ;

BALLENTINE, R ;

FRANKEL, LS .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1981, 38 (03) :365-368

[5] USE OF ALLOPURINOL FOR PREVENTION AND CONTROL OF HYPERURICEMIA IN PATIENTS WITH NEOPLASTIC DISEASE [J].

DECONTI, RC ;

CALABRESI, P .

NEW ENGLAND JOURNAL OF MEDICINE, 1966, 274 (09) :481-+

[6] METABOLIC STUDIES OF ALLOPURINOL AN INHIBITOR OF XANTHINE OXIDASE [J].

ELION, GB ;

KOVENSKY, A ;

HITCHING.GH ;

METZ, E ;

RUNDLES, RW .

BIOCHEMICAL PHARMACOLOGY, 1966, 15 (07) :863-&

[7] RENAL CLEARANCE OF OXIPURINOL CHIEF METABOLITE OF ALLOPURINOL [J].

ELION, GB ;

YU, TF ;

GUTMAN, AB ;

HITCHINGS, GH .

AMERICAN JOURNAL OF MEDICINE, 1968, 45 (01) :69-+

[8]

GIBALDI M, 1975, PHARMACOKINETICS, P73

[9]

HANDE K, 1978, CLIN PHARMACOL THER, V23, P598

[10] HYPERURICEMIC ACUTE RENAL-FAILURE [J].

KJELLSTRAND, CM ;

CAMPBELL, DC ;

HARTITZS.BV ;

BUSELMEI.TJ .

ARCHIVES OF INTERNAL MEDICINE, 1974, 133 (03) :349-359

← 1 2 →